Central Nervous System Disorders is under clinical development by Neuroplast and currently in Phase I for Amyotrophic Lateral Sclerosis.

Team Gleason and Synchron Expand Collaboration to Drive Awareness of The Synchron BCI Community to Advance Brain Computer Interface Technology ...

Announcing a new publication for Acta Materia Medica journal. Complex biological mechanisms and unidentified therapeutic targets for amyotrophic lateral sclerosis (ALS) significantly hinder the develo ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing ...

The Vermont Department of Health recently released data from the state's first registry for the disease Amyotrophic Lateral ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Neurodegenerative diseases pose a serious threat to public health, with an increasing impact among the elderly population.

Chinese startup NeuroXess' new BCI can decipher the complex Chinese language in brain, operate a robotic arm and interact with AI.

Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not ...

Ancient Viral DNA in the Human Genome Linked to Multiple Sclerosis and Amyotrophic Lateral Sclerosis Oct ... Epstein-Barr Virus and Brain Cross-Reactivity: Possible Mechanism for Multiple Sclerosi ...

Ancient Viral DNA in the Human Genome Linked to Multiple Sclerosis and Amyotrophic Lateral Sclerosis Oct ... Epstein-Barr Virus and Brain Cross-Reactivity: Possible Mechanism for Multiple Sclerosi ...

Thanks to awareness-raising initiatives like the Ice Bucket Challenge, we all have a better appreciation of amyotrophic ...